<SEC-DOCUMENT>0000950103-25-014236.txt : 20251104
<SEC-HEADER>0000950103-25-014236.hdr.sgml : 20251104
<ACCEPTANCE-DATETIME>20251104143919
ACCESSION NUMBER:		0000950103-25-014236
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20251104
DATE AS OF CHANGE:		20251104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BARCLAYS BANK PLC
		CENTRAL INDEX KEY:			0000312070
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287303
		FILM NUMBER:		251448221

	BUSINESS ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP
		BUSINESS PHONE:		0044-20-3555-4619

	MAIL ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK PLC /ENG/
		DATE OF NAME CHANGE:	19990402

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK INTERNATIONAL LTD
		DATE OF NAME CHANGE:	19850313
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp236849_424b2-7853wfps.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="width: 53%"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">PRICING SUPPLEMENT
    dated October 31, 2025</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">(To the Prospectus
    dated May 15, 2025,</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">the Prospectus
    Supplement dated May 15, 2025,</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">the Product Supplement
    No. WF-1 dated May 20, 2025 and</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">the Underlying
    Supplement dated May 15, 2025)</FONT></P></TD>
    <TD STYLE="width: 47%"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Filed Pursuant
    to Rule 424(b)(2)</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Registration Statement
    No. 333-287303</FONT></P></TD></TR>
  <TR>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-size: 10pt"><IMG SRC="image_001.jpg" ALT="barclays PLC logo" STYLE="height: 42px; width: 179px"></FONT></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EDEFEE">
    <TD STYLE="padding: 4pt; width: 100%">
    <P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Barclays Bank PLC</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left; color: #BB0826">Global Medium-Term Notes, Series
A</P></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #D5D9D8">
    <TD STYLE="padding: 4pt; width: 100%">
    <P STYLE="color: #BB0826; font: bold 13pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">$2,039,000 Market Linked Securities&mdash;Upside
Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P>
    <P STYLE="color: #BB0826; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Principal at Risk Securities
Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</P></TD></TR>
  </TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD STYLE="padding: 4pt; width: 100%">
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Linked
to the S&amp;P 500<SUP>&reg;</SUP> Index (the &ldquo;<U>Index</U>&rdquo;)</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Unlike
ordinary debt securities, the securities do not pay interest or repay a fixed amount of principal at maturity. Instead, the securities
provide for a maturity payment amount that may be greater than, equal to or less than the principal amount of the securities, depending
on the performance of the Index from the starting level to the ending level. The maturity payment amount will reflect the following terms:</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.5in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;If
the level of the Index increases, you will receive the principal amount plus a positive return equal to 100% of the percentage increase
in the level of the Index from the starting level to the ending level, subject to a maximum upside return at maturity of 18.50% of the
principal amount. As a result of the maximum upside return, the maximum maturity payment amount will be $1,185.00 per security if the
Index appreciates.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.5in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white">&nbsp;&nbsp;If
the level of the Index decreases but the decrease is not more than 15%, you will receive the principal amount </FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><I>plus</I>
a positive return equal to the absolute value of the percentage decline in the level of the Index from the starting level to the ending
level, which will be effectively capped at a positive return of 15%.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.5in; text-align: justify; text-indent: -13.7pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;If
the level of the Index decreases by more than 15%, you will receive less than the principal amount and will have 1-to-1 downside exposure
to the decrease in the level of the Index in excess of 15%.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Investors
may lose up to 85% of the principal amount.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Any
payment on the securities, including any repayment of principal, is subject to the creditworthiness of Barclays Bank PLC and is not guaranteed
by any third party. If Barclays Bank PLC were to default on its payment obligations or become subject to the exercise of any U.K. Bail-in
Power (as described on page PS-6 of this pricing supplement) by the relevant U.K. resolution authority, you might not receive any amounts
owed to you under the securities. See &ldquo;Selected Risk Considerations&rdquo; and &ldquo;Consent to U.K. Bail-in Power&rdquo; in this
pricing supplement and &ldquo;Risk Factors&rdquo; in the accompanying prospectus supplement.</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;No
periodic interest payments or dividends</FONT></P>
    <P STYLE="color: white; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 4.3pt 0pt 0.25in; text-align: justify; text-indent: -13.5pt"><FONT STYLE="font-family: Wingdings">n</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;No
exchange listing; designed to be held to maturity</FONT></P></TD></TR>
  </TABLE>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">See &ldquo;Additional Information about the
Issuer and the Securities&rdquo; on page PS-4 of this pricing supplement. The securities will have the terms specified in the prospectus
dated May 15, 2025, the prospectus supplement dated May 15, 2025, the product supplement no. WF-1 dated May 20, 2025 and the underlying
supplement dated May 15, 2025, as supplemented or superseded by this pricing supplement.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The securities have complex features and
investing in the securities involves risks not associated with an investment in conventional debt securities. See &ldquo;Selected Risk
Considerations&rdquo; on page PS-10 herein, &ldquo;Risk Factors&rdquo; beginning on page PS-3 of the product supplement and &ldquo;Risk
Factors&rdquo; beginning on page S-9 of the prospectus supplement.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The securities constitute our unsecured and
unsubordinated obligations. The securities are not deposit liabilities of Barclays Bank PLC and are not covered by the U.K. Financial
Services Compensation Scheme or insured by the U.S. Federal Deposit Insurance Corporation or any other governmental agency or deposit
insurance agency of the United States, the United Kingdom or any other jurisdiction.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Neither the U.S. Securities and Exchange
Commission (the &ldquo;<U>SEC</U>&rdquo;) nor any state securities commission has approved or disapproved of these securities or determined
that this pricing supplement is truthful or complete. Any representation to the contrary is a criminal offense.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">We may use this pricing supplement in the
initial sale of the securities. In addition, Barclays Capital Inc. or any other of our affiliates may use this pricing supplement in
market resale transactions in any of the securities after their initial sale. Unless we or our agent informs you otherwise in the confirmation
of sale, this pricing supplement is being used in a market resale transaction.</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial
owner of the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial
owner of the securities acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority. See &ldquo;Consent to U.K. Bail-in Power&rdquo; on page PS-6 of this pricing supplement.</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 21%; text-align: justify; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 27%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Original Offering Price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="width: 26%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Agent Discount<SUP>(2), (3)</SUP></B></FONT></TD>
    <TD STYLE="width: 26%; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proceeds to Barclays Bank PLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Per Security</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$25.70</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$974.30</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #E0E3E2">
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2,039,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$52,402.30</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,986,597.70</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-size: 9pt"><SUP>(1)</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9pt">Our
                                            estimated value of the securities on the pricing date, based on our internal pricing models,
                                            is $957.40 per security. The estimated value is less than the original offering price of
                                            the securities. See &ldquo;Additional Information Regarding Our Estimated Value of the Securities&rdquo;
                                            on page PS-5 of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-size: 9pt"><SUP>(2)</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9pt">Wells
                                            Fargo Securities, LLC (&ldquo;<U>WFS</U>&rdquo;) and Barclays Capital Inc. are the agents
                                            for the distribution of the securities and are acting as principal. The agent will receive
                                            an underwriting discount of $25.70 per security. Barclays Capital Inc. will sell the securities
                                            to WFS at the original offering price of the securities less a concession of $25.70 per security.
                                            WFS may provide dealers, which may include Wells Fargo Advisors (&ldquo;<U>WFA</U>&rdquo;)
                                            (the trade name of the retail brokerage business of WFS&rsquo;s affiliates, Wells Fargo Clearing
                                            Services, LLC and Wells Fargo Advisors Financial Network, LLC), with a selling concession
                                            of $20.00 per security. In addition to the concession allowed to WFA, WFS may pay $0.75 per
                                            security of the agent&rsquo;s discount to WFA as a distribution expense fee for each security
                                            sold by WFA. See &ldquo;Terms of the Securities&mdash;Supplemental Plan of Distribution&rdquo;
                                            in this pricing supplement for further information.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.2in"><FONT STYLE="font-size: 9pt"><SUP>(3)</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9pt">In
                                            respect of certain securities sold in this offering, Barclays Capital Inc. may pay a fee
                                            of up to $2.00 per security to selected securities dealers in consideration for marketing
                                            and other services in connection with the distribution of the securities to other securities
                                            dealers.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: justify; font-size: 12pt; font-weight: bold">Wells Fargo Securities</TD>
    <TD STYLE="width: 50%; text-align: right; font-size: 12pt; font-weight: bold">Barclays Capital Inc.</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="padding: 4pt; color: white; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; text-align: center; background-color: #5E8AB4"><FONT STYLE="font-size: 12pt">Terms
of the Securities</FONT></P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 20%; border: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Issuer:</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 80%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Barclays Bank PLC</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Market Measure<SUP>1</SUP>:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">S&amp;P 500<SUP>&reg;</SUP> Index (Bloomberg ticker symbol &ldquo;SPX&lt;Index&gt;&rdquo;) (the &ldquo;<U>Index</U>&rdquo;)</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Pricing Date:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">October 31, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Issue Date:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">November 5, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Calculation Day<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">May 1, 2028</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Stated Maturity Date<SUP>2</SUP>:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">May 4, 2028</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Principal Amount:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">$1,000 per security. References in this pricing supplement to a &ldquo;<U>security</U>&rdquo; are to a security with a principal amount of $1,000.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Maturity Payment Amount: </B></FONT></TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you will be
entitled to receive a cash payment per security in U.S. dollars equal to the maturity payment amount. The &ldquo;<U>maturity payment
amount</U>&rdquo; per security will equal:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;&#9;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;if
the ending level is greater than the starting level: $1,000 <I>plus</I> the lesser of:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;$1,000
&times; index return &times; upside participation rate; and</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
maximum upside return;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;&#9;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;if
the ending level is less than or equal to the starting level, but greater than or equal to the threshold level: </FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">$1,000 + ($1,000 &times; absolute value return); or</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;&#9;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;if
the ending level is less than the threshold level: </FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">$1,000 + [$1,000 &times; (index return + buffer amount)]</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If the ending level is less than the threshold
level, you will lose up to 85% of the principal amount of your securities at maturity. Any payment on the securities, including any repayment
of principal, is subject to the creditworthiness of Barclays Bank PLC and is not guaranteed by any third party. If Barclays Bank PLC
were to default on its payment obligations or become subject to the exercise of any U.K. Bail-in Power by the relevant U.K. resolution
authority, you might not receive any amounts owed to you under the securities.</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Maximum Upside Return:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The &ldquo;<U>maximum upside return</U>&rdquo; is 18.50% of the principal amount ($185.00 per security). As a result of the maximum upside return, the maximum maturity payment amount if the Index appreciates will be $1,185.00 per security.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Upside Participation Rate:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">100%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Threshold Level:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,814.17, which is equal to 85% of the starting level</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Buffer Amount: </B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">15%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Index Return:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The &ldquo;<U>index return</U>&rdquo; is
the percentage change from the starting level to the ending level, measured as follows:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><U>ending level &ndash; starting level</U></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;&nbsp;&#9;starting
level</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Absolute Value Return:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The &ldquo;<U>absolute value return</U>&rdquo; is the absolute value of the index return. For example, a -5% index return will result in a +5% absolute value return.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Starting Level:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,840.20, which is the closing level of the Index on the pricing date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Ending Level:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The &ldquo;<U>ending level</U>&rdquo; will be the closing level of the Index on the calculation day.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 20%; border: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Closing Level: </B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 80%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<U>Closing level</U>&rdquo; has the meaning set forth under &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Index&mdash;Certain Definitions&rdquo; in the product supplement.</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Additional Terms:</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Terms used in this pricing supplement, but not defined herein, will have the meanings ascribed to them in the product supplement, <I>provided</I> that terms used in this pricing supplement, but not defined herein or in the product supplement, will have the meanings ascribed to them in the prospectus supplement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Calculation Agent:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Barclays Bank PLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Tax Considerations:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For a discussion of the tax considerations relating to ownership and disposition of the securities, see &ldquo;Tax Considerations.&rdquo;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Denominations:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">$1,000 and any integral multiple of $1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">06746EC94 / US06746EC943</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: white 1.5pt solid; border-bottom: white 1.5pt solid; border-left: white 1.5pt solid; background-color: #E0E3E2"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Supplemental Plan of Distribution:</B></FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Wells Fargo Securities, LLC (&ldquo;<U>WFS</U>&rdquo;)
and Barclays Capital Inc. will act as agents for the securities. The agent will receive an underwriting discount of $25.70 per security.
Barclays Capital Inc. will sell the securities to WFS at the original offering price of the securities less a concession of $25.70 per
security. WFS may provide dealers, which may include Wells Fargo Advisors (&ldquo;<U>WFA</U>&rdquo;) (the trade name of the retail brokerage
business of WFS&rsquo;s affiliates, Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network, LLC), with a selling
concession of $20.00 per security. In addition to the concession allowed to WFA, WFS may pay $0.75 per security of the agent&rsquo;s
discount to WFA as a distribution expense fee for each security sold by WFA.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, in respect of certain securities
sold in this offering, Barclays may pay a fee of up to $2.00 per security to selected securities dealers in consideration for marketing
and other services in connection with the distribution of the securities to other securities dealers.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Barclays Bank PLC or its affiliate will enter
into swap agreements or related hedge transactions with one of its other affiliates or unaffiliated counterparties in connection with
the sale of the securities. If WFS, Barclays Capital Inc. or an affiliate of either agent participating as a dealer in the distribution
of the securities conducts hedging activities for Barclays Bank PLC in connection with the securities, such agent or participating dealer
will expect to realize a projected profit from such hedging activities, and this projected profit will be in addition to any discount,
concession or fee received in connection with the sale of the securities to you. This additional projected profit may create a further
incentive for the agents or participating dealers to sell the securities to you.</P></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt"><SUP>&nbsp;</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt"><SUP></SUP></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt"><SUP>1</SUP> If
the Index is discontinued or if the sponsor of the Index fails to publish the Index, the calculation agent may select a successor index
or, if no successor index is available, will calculate the value to be used as the closing level of the Index. In addition, the calculation
agent will calculate the value to be used as the closing level of the Index in the event of certain changes in or modifications to the
Index. For more information, see &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Index&mdash;Adjustments
to an Index&rdquo; and &ldquo;&mdash;Discontinuance of an Index&rdquo; in the accompanying product supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt"><SUP>2</SUP> If
the calculation day is not a trading day, the calculation day will be postponed to the next succeeding trading day. The calculation day
will also be postponed if a market disruption event occurs on the calculation day as described under &ldquo;General Terms of the Securities&mdash;Consequences
of a Market Disruption Event; Postponement of a Calculation Day&mdash;Securities Linked to a Single Market Measure&rdquo; in the accompanying
product supplement. In addition, the stated maturity date will be postponed if that day is not a business day or if the calculation day
is postponed as described under &ldquo;General Terms of the Securities&mdash;Payment Dates&rdquo; in the accompanying product supplement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #5E8AB4"><FONT STYLE="font-size: 12pt">Additional
Information about the Issuer and the Securities</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should read this pricing supplement together
with the prospectus dated May 15, 2025, as supplemented by the prospectus supplement dated May 15, 2025 relating to our Global Medium-Term
Notes, Series A, of which these securities are a part, the product supplement no. WF-1 dated May 20, 2025 and the underlying supplement
dated May 15, 2025. This pricing supplement, together with the documents listed below, contains the terms of the securities and supersedes
all prior or contemporaneous oral statements as well as any other written materials including preliminary or indicative pricing terms,
correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should
carefully consider, among other things, the matters set forth under &ldquo;Risk Factors&rdquo; in the prospectus supplement and &ldquo;Selected
Risk Considerations&rdquo; in this pricing supplement, as the securities involve risks not associated with conventional debt securities.
We urge you to consult your investment, legal, tax, accounting and other advisors before you invest in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent the information or terms in this
pricing supplement are different from or inconsistent with the information or terms in the prospectus, prospectus supplement, product
supplement or underlying supplement, the information and terms in this pricing supplement will control. To the extent the information
or terms in the product supplement are different from or inconsistent with the information or terms in the prospectus or prospectus supplement,
the information and terms in the product supplement will control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may access these documents on the SEC website
at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prospectus dated May 15, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm" STYLE="color: Blue; text-decoration: underline">http://www.sec.gov/Archives/edgar/data/312070/000119312525120720/d925982d424b2.htm</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prospectus Supplement dated May 15, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm" STYLE="color: Blue; text-decoration: underline">http://www.sec.gov/Archives/edgar/data/312070/000095010325006051/dp228678_424b2-prosupp.htm</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Product Supplement No. WF-1 dated May 20, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006260/dp229046_424b2-wf1.htm" STYLE="color: Blue; text-decoration: underline">http://www.sec.gov/Archives/edgar/data/312070/000095010325006260/dp229046_424b2-wf1.htm</A>
</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Underlying Supplement dated May 15, 2025:<BR>
<A HREF="http://www.sec.gov/Archives/edgar/data/312070/000095010325006053/dp228705_424b2-underl.htm" STYLE="color: Blue; text-decoration: underline">http://www.sec.gov/Archives/edgar/data/312070/000095010325006053/dp228705_424b2-underl.htm</A></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our SEC file number is 1-10257. As used in this
pricing supplement, &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; refer to Barclays Bank PLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #5E8AB4"><FONT STYLE="font-size: 12pt">Additional
Information Regarding Our Estimated Value of the Securities</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our internal pricing models take into account
a number of variables and are based on a number of subjective assumptions, which may or may not materialize, typically including volatility,
interest rates and our internal funding rates. Our internal funding rates (which are our internally published borrowing rates based on
variables, such as market benchmarks, our appetite for borrowing and our existing obligations coming to maturity) may vary from the levels
at which our benchmark debt securities trade in the secondary market. Our estimated value on the pricing date is based on our internal
funding rates. Our estimated value of the securities might be lower if such valuation were based on the levels at which our benchmark
debt securities trade in the secondary market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our estimated value of the securities on the pricing
date is less than the original offering price of the securities. The difference between the original offering price of the securities
and our estimated value of the securities results from several factors, including any sales commissions to be paid to Barclays Capital
Inc. or another affiliate of ours, any selling concessions, discounts, commissions or fees to be allowed or paid to non-affiliated intermediaries,
the estimated profit that we or any of our affiliates expect to earn in connection with structuring the securities, the estimated cost
that we may incur in hedging our obligations under the securities, and estimated development and other costs that we may incur in connection
with the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our estimated value on the pricing date is not
a prediction of the price at which the securities may trade in the secondary market, nor will it be the price at which Barclays Capital
Inc. may buy or sell the securities in the secondary market. Subject to normal market and funding conditions, Barclays Capital Inc. or
another affiliate of ours intends to offer to purchase the securities in the secondary market but it is not obligated to do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assuming that all relevant factors remain constant
after the pricing date, the price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market, if
any, and the value that we may initially use for customer account statements, if we provide any customer account statements at all, may
exceed our estimated value on the pricing date for a temporary period expected to be approximately three months after the initial issue
date of the securities because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost
of hedging our obligations under the securities and other costs in connection with the securities that we will no longer expect to incur
over the term of the securities. We made such discretionary election and determined this temporary reimbursement period on the basis of
a number of factors, which may include the tenor of the securities and/or any agreement we may have with the distributors of the securities.
The amount of our estimated costs that we effectively reimburse to investors in this way may not be allocated ratably throughout the reimbursement
period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the initial issue
date of the securities based on changes in market conditions and other factors that cannot be predicted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>We urge you to read the &ldquo;Selected Risk
Considerations&rdquo; beginning on page PS-10 of this pricing supplement.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #5E8AB4"><FONT STYLE="font-size: 12pt">Consent
to U.K. Bail-in Power</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between us and any holder or beneficial owner of
the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial owner
of the securities acknowledges, accepts, agrees to be bound by and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under the U.K. Banking Act 2009, as amended, the
relevant U.K. resolution authority may exercise a U.K. Bail-in Power in circumstances in which the relevant U.K. resolution authority
is satisfied that the resolution conditions are met. These conditions include that a U.K. bank or investment firm is failing or is likely
to fail to satisfy the Financial Services and Markets Act 2000 (the &ldquo;<U>FSMA</U>&rdquo;) threshold conditions for authorization
to carry on certain regulated activities (within the meaning of section 55B FSMA) or, in the case of a U.K. banking group company that
is a European Economic Area (&ldquo;<U>EEA</U>&rdquo;) or third country institution or investment firm, that the relevant EEA or third
country relevant authority is satisfied that the resolution conditions are met in respect of that entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The U.K. Bail-in Power includes any write-down,
conversion, transfer, modification and/or suspension power, which allows for (i) the reduction or cancellation of all, or a portion, of
the principal amount of, or interest on, or any other amounts payable on, the securities; (ii) the conversion of all, or a portion, of
the principal amount of, or interest on, or any other amounts payable on, the securities into shares or other securities or other obligations
of Barclays Bank PLC or another person (and the issue to, or conferral on, the holder or beneficial owner of the securities of such shares,
securities or obligations); (iii) the cancellation of the securities and/or (iv) the amendment or alteration of the maturity of the securities,
or the amendment of the amount of interest or any other amounts due on the securities, or the dates on which interest or any other amounts
become payable, including by suspending payment for a temporary period; which U.K. Bail-in Power may be exercised by means of a variation
of the terms of the securities solely to give effect to the exercise by the relevant U.K. resolution authority of such U.K. Bail-in Power.
Each holder and beneficial owner of the securities further acknowledges and agrees that the rights of the holders or beneficial owners
of the securities are subject to, and will be varied, if necessary, solely to give effect to, the exercise of any U.K. Bail-in Power by
the relevant U.K. resolution authority. For the avoidance of doubt, this consent and acknowledgment is not a waiver of any rights holders
or beneficial owners of the securities may have at law if and to the extent that any U.K. Bail-in Power is exercised by the relevant U.K.
resolution authority in breach of laws applicable in England.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information, please see &ldquo;Selected
Risk Considerations&mdash;Risks Relating to the Issuer&mdash;You May Lose Some or All of Your Investment If Any U.K. Bail-in Power Is
Exercised by the Relevant U.K. Resolution Authority&rdquo; in this pricing supplement as well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk
Factors&mdash;Risks Relating to the Securities Generally&mdash;Regulatory action in the event a bank or investment firm in the Group is
failing or likely to fail, including the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers,
could materially adversely affect the value of any securities&rdquo; and &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Under
the terms of the securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo;
in the accompanying prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #5E8AB4"><FONT STYLE="font-size: 12pt">Investor
Considerations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities are not appropriate for all
investors. The securities <I>may</I> be an appropriate investment for you if all of the following statements are true:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You do not seek an investment that produces periodic
interest or coupon payments or other sources of current income.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You understand that the absolute value return
feature applies only if the Index decreases from the starting level but not by more than 15.00%, that any positive return in the event
that the ending level is less than the starting level is limited to 15.00% and that any decline in the ending level from the starting
level by more than 15.00% will result in a loss, rather than a positive return, on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to accept the risk that,
if the ending level is less than the starting level by more than 15%, you will lose up to 85% of the principal amount of your securities
at maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to accept that any potential return on the securities
if the Index appreciates is limited to the maximum upside return.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to accept the risks
associated with an investment linked to the performance of the Index, as explained in more detail in the &ldquo;Selected Risk Considerations&rdquo;
section of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You understand and accept that you will not be
entitled to receive dividends or distributions that may be paid to holders of the securities composing the Index, nor will you have any
voting rights with respect to the securities composing the Index.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You do not seek an investment for which there
will be an active secondary market and you are willing and able to hold the securities to maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to assume our credit
risk for all payments on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are willing and able to consent to the exercise
of any U.K. Bail-in Power by any relevant U.K. resolution authority.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities may <I>not</I> be an appropriate
investment for you if <I>any</I> of the following statements are true:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that produces periodic
interest or coupon payments or other sources of current income.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that provides for the
full repayment of principal at maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to accept that the
absolute value return feature applies only if the Index decreases from the starting level but not by more than 15.00%, that any positive
return in the event that the ending level is less than the starting level is limited to 15.00% or that any decline in the ending level
from the starting level by more than 15.00% will result in a loss, rather than a positive return, on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to accept the risk
that, if the ending level is less than the starting level by more than 15%, you will lose up to 85% of the principal amount of your securities
at maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment with uncapped exposure to any positive performance
of the Index.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to accept the risks
associated with an investment linked to the performance of the Index, as explained in more detail in the &ldquo;Selected Risk Considerations&rdquo;
section of this pricing supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment that entitles you to dividends
or distributions on, or voting rights related to, the securities composing the Index.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You seek an investment for which there will be
an active secondary market and/or you are unwilling or unable to hold the securities to maturity.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to assume our credit
risk for all payments on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&sect;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">You are unwilling or unable to consent to the
exercise of any U.K. Bail-in Power by any relevant U.K. resolution authority.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The considerations identified above are not
exhaustive. Whether or not the securities are an appropriate investment for you will depend on your individual circumstances, and you
should reach an investment decision only after you and your investment, legal, tax, accounting and other advisors have carefully considered
the appropriateness of an</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>investment in the securities in light of your particular circumstances. You should also review carefully the
&ldquo;Selected Risk Considerations&rdquo; beginning on page PS-10 of this pricing supplement and the &ldquo;Risk Factors&rdquo; beginning
on page PS-3 of the accompanying product supplement and the &ldquo;Risk Factors&rdquo; beginning on page S-9 of the accompanying prospectus
supplement for risks related to an investment in the securities. For more information about the Index, please see the section titled &ldquo;The
S&amp;P 500<SUP>&reg;</SUP> Index&rdquo; below.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #5E8AB4"><FONT STYLE="font-size: 12pt">Determining
the Maturity Payment Amount</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you will receive
a cash payment per security (the maturity payment amount) calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #5E8AB4"><FONT STYLE="font-size: 12pt">Selected
Risk Considerations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An investment in the securities involves significant
risks. Investing in the securities is not equivalent to investing directly in the Index or its components. Some of the risks that apply
to an investment in the securities are summarized below, but we urge you to read the more detailed explanation of risks relating to the
securities generally in the &ldquo;Risk Factors&rdquo; sections of the product supplement and prospectus supplement. You should not purchase
the securities unless you understand and can bear the risks of investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Securities
Generally</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>If The Ending Level Is Less Than The Threshold
Level, You Will Lose Up To 85% Of The Principal Amount Of Your Securities At Maturity</B> &mdash; If the ending level is less than the
threshold level, the maturity payment amount will be less than the principal amount and you will have full downside exposure to the decrease
in the level of the Index in excess of the buffer amount, resulting in a loss of 1% of the principal amount for every 1% decline in the
Index in excess of the buffer amount. The threshold level is 85% of the starting level. As a result, you may lose up to 85% of the principal
amount at maturity, even if the level of the Index is greater than or equal to the starting level or the threshold level at certain times
during the term of the securities. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Your Potential For A Positive Return From
Depreciation Of The Index Is Limited </B>&mdash; The absolute value return feature applies only if the ending level is less than the starting
level but greater than or equal to the threshold level, which is equal to 85.00% of the starting level. Thus, any potential return on
the securities in the event that the ending level is less than the starting level is limited to 15.00%. Any decline in the ending level
from the starting level by more than 15.00% will result in a loss, rather than a positive return, on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Your Return Will Be Limited To The Maximum
Upside Return If The Index Appreciates And May Be Lower Than The Return On A Direct Investment In The Securities Composing The Index</B>
&mdash; The opportunity to participate in the possible increases in the level of the Index through an investment in the securities will
be limited because any positive return on the securities if the Index appreciates will not exceed the maximum upside return, regardless
of any increase in the level of the Index, which may be significant. Therefore, your return on the securities may be lower than the return
on a direct investment in the Index. Furthermore, the effect of the upside participation rate will be progressively reduced for all ending
levels exceeding the ending level at which the maximum upside return is reached.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>No Periodic Interest Will Be Paid On The Securities
</B>&mdash; No periodic payments of interest will be made on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Any Payment On The Securities Will Be Determined
Based On The Closing Levels Of The Index On The Dates Specified</B> &mdash; Any payment on the securities will be determined based on
the closing levels of the Index on the dates specified. You will not benefit from any more favorable level of the Index determined at
any other time.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Owning The Securities Is Not The Same As Owning
The Securities Composing The Index</B> &mdash; The return on your securities may not reflect the return you would realize if you actually
owned the securities composing the Index. For instance, as a holder of the securities, you will not have voting rights or rights to receive
cash dividends or other distributions or any other rights that holders of the securities composing the Index would have.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>No Assurance That The Investment View Implicit
In The Securities Will Be Successful</B> &mdash; It is impossible to predict whether and the extent to which the level of the Index will
rise or fall. There can be no assurance that the ending level will not be less than the threshold level. The level of the Index will be
influenced by complex and interrelated political, economic, financial and other factors that affect the Index and the securities composing
the Index. You should be willing to accept the downside risks associated with equities in general and the Index in particular, and the
risk of losing up to 85% of the principal amount.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The U.S. Federal Income Tax Consequences Of
An Investment In The Securities Are Uncertain</B> &mdash; There is no direct legal authority regarding the proper U.S. federal income
tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service (the &ldquo;IRS&rdquo;). Consequently,
significant aspects of the tax treatment of the securities are uncertain, and the IRS or a court might not agree with the treatment of
the securities as prepaid forward contracts, as described below under &ldquo;Tax Considerations.&rdquo; If the IRS were successful in
asserting an alternative treatment for the securities, the tax consequences of the ownership and disposition of the securities could be
materially and adversely affected.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition, in 2007
the Treasury Department and the IRS released a notice requesting comments on various issues regarding the U.S. federal income tax treatment
of &ldquo;prepaid forward contracts&rdquo; and similar instruments. Any Treasury regulations or other guidance promulgated after consideration
of these issues could materially and adversely affect the tax consequences of an investment in the securities, possibly with retroactive
effect. You should review carefully the sections of the accompanying prospectus supplement entitled &ldquo;Material U.S. Federal Income
Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes Treated as Prepaid Forward Contracts&rdquo; and, if you are a non-U.S.
holder, &ldquo;&mdash;Tax Consequences to Non-U.S. Holders,&rdquo; and consult your tax advisor regarding the U.S. federal tax consequences
of an investment in the securities (including possible alternative treatments and the issues presented by the 2007 notice), as well as
tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities Are Subject To The Credit Risk
Of Barclays Bank PLC</B> &mdash; The securities are unsecured and unsubordinated debt obligations of the issuer, Barclays Bank PLC, and
are not, either directly or indirectly, an obligation of any third party. Any payment to be made on the securities, including any repayment
of principal, is subject to the ability of Barclays Bank PLC to satisfy its obligations as they come due and is not guaranteed by any
third party. As a result, the actual and perceived creditworthiness of Barclays Bank PLC may affect the market value of the securities
and, in the event Barclays Bank PLC were to default on its obligations, you might not receive any amount owed to you under the terms of
the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>You May Lose Some Or All Of Your Investment
If Any U.K. Bail-In Power Is Exercised By The Relevant U.K. Resolution Authority &mdash; </B>Notwithstanding and to the exclusion of any
other term of the securities or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial
owner of the securities (or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder or beneficial
owner of the securities acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the relevant
U.K. resolution authority as set forth under &ldquo;Consent to U.K. Bail-in Power&rdquo; in this pricing supplement. Accordingly, any
U.K. Bail-in Power may be exercised in such a manner as to result in you and other holders and beneficial owners of the securities losing
all or a part of the value of your investment in the securities or receiving a different security from the securities, which may be worth
significantly less than the securities and which may have significantly fewer protections than those typically afforded to debt securities.
Moreover, the relevant U.K. resolution authority may exercise the U.K. Bail-in Power without providing any advance notice to, or requiring
the consent of, the holders and beneficial owners of the securities. The exercise of any U.K. Bail-in Power by the relevant U.K. resolution
authority with respect to the securities will not be a default or an Event of Default (as each term is defined in the senior debt securities
indenture) and the trustee will not be liable for any action that the trustee takes, or abstains from taking, in either case, in accordance
with the exercise of the U.K. Bail-in Power by the relevant U.K. resolution authority with respect to the securities. See &ldquo;Consent
to U.K. Bail-in Power&rdquo; in this pricing supplement as well as &ldquo;U.K. Bail-in Power,&rdquo; &ldquo;Risk Factors&mdash;Risks Relating
to the Securities Generally&mdash;Regulatory action in the event a bank or investment firm in the Group is failing or likely to fail,
including the exercise by the relevant U.K. resolution authority of a variety of statutory resolution powers, could materially adversely
affect the value of any securities&rdquo; and &ldquo;Risk Factors&mdash;Risks Relating to the Securities Generally&mdash;Under the terms
of the securities, you have agreed to be bound by the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority&rdquo;
in the accompanying prospectus supplement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Index</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Index Reflects The Price Return Of The
Securities Composing The Index, Not The Total Return</B> &mdash; The return on the securities is based on the performance of the Index,
which reflects changes in the market prices of the securities composing the Index. The Index is not a &ldquo;total return&rdquo; index
that, in addition to reflecting those price returns, would also reflect dividends paid on the securities composing the Index. Accordingly,
the return on the securities will not include such a total return feature.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We Cannot Control Actions Of Any Of The Unaffiliated
Companies Whose Securities Are Included As Components Of The Index </B>&mdash; Actions by any company whose securities are components
of the Index may have an adverse effect on the price of its security, the closing level of the Index on the calculation day and the value
of the securities. These unaffiliated companies will not be involved in the offering of the securities and will have no obligations with
respect to the securities, including any obligation to take our or your interests into consideration for any reason. These companies will
not receive any of the proceeds of the offering of the securities and will not be responsible for, and will not have participated in,
the determination of the timing of, prices for, or quantities of, the securities to be issued. These companies will not be involved with
the administration, marketing or trading of the securities and will have no obligations with respect to any amounts to be paid to you
on the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We And Our Affiliates Have No Affiliation
With The Index Sponsor And Have Not Independently Verified Its Public Disclosure Of Information</B> &mdash; We, our affiliates and WFS
and its affiliates are not affiliated in any way with the index sponsor and have no ability to control or predict its actions, including
any errors in or discontinuation of disclosure regarding its methods or policies relating to the calculation of the Index. We have derived
the information about the Index contained in this pricing supplement and the accompanying underlying supplement from publicly available
information, without independent verification. You, as an investor in the securities, should make your own investigation into the Index
and the index sponsor. The index sponsor will not be involved in the offering of the securities made hereby in any way, and the index
sponsor does not have any obligation to consider your interests as an owner of the securities in taking any actions that might affect
the value of the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Adjustments To The Index Could Adversely Affect
The Value Of The Securities And The Amount You Will Receive At Maturity</B> &mdash; The sponsor of the Index (the &ldquo;<U>index sponsor</U>&rdquo;)
may add, delete, substitute or adjust the securities composing the Index or make other methodological changes to the Index that could
affect its performance. The calculation agent will calculate the value to be used as the closing level of the Index in the event of certain
material changes in or modifications to the Index. In addition, the index sponsor may also discontinue or suspend calculation or publication
of the Index at any time. Under these circumstances, the calculation agent may select a successor index that the calculation agent determines
to be comparable to the discontinued index or, if no successor index is available, the calculation agent will determine the value to be
used as the closing level of the Index. Any of these actions could adversely affect the level of the Index and, consequently, the value
of the securities. See &ldquo;General Terms of the </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">Securities&mdash;Certain
Terms for Securities Linked to an Index&mdash;Adjustments to an Index&rdquo; and &ldquo;&mdash;Discontinuance of an Index&rdquo; in the
accompanying product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Historical Performance Of The Index Is
Not An Indication Of Its Future Performance &mdash;</B> The historical performance of the Index should not be taken as an indication of
the future performance of the Index. It is impossible to predict whether the closing level of the Index will fall or rise during the term
of the securities, in particular in the environment in the last several years, which has been characterized by volatility across a wide
range of asset classes. Past fluctuations and trends in the level of the Index are not necessarily indicative of fluctuations or trends
that may occur in the future.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to Conflicts
of Interest</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Potentially Inconsistent Research, Opinions
Or Recommendations By Barclays Capital Inc., WFS Or Their Respective Affiliates</B> &mdash; Barclays Capital Inc., WFS or their respective
affiliates may publish research from time to time on financial markets and other matters that may influence the value of the securities
or express opinions or provide recommendations that are inconsistent with purchasing or holding the securities. Any research, opinions
or recommendations expressed by Barclays Capital Inc., WFA or their respective affiliates may not be consistent with each other and may
be modified from time to time without notice. You should make your own independent investigation of the Index and the merits of investing
in the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>We, Our Affiliates And Any Other Agent And/Or
Participating Dealer May Engage In Various Activities Or Make Determinations That Could Materially Affect Your Securities In Various Ways
And Create Conflicts Of Interest</B> &mdash; We, our affiliates, WFS and any dealer participating in the distribution of the securities
(a &ldquo;<U>participating dealer</U>&rdquo;) may play a variety of roles in connection with the issuance of the securities, as described
below. In performing these roles, our economic interests and the economic interests of our affiliates, WFS and any participating dealer
are potentially adverse to your interests as an investor in the securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In connection with
our normal business activities and in connection with hedging our obligations under the securities, we and our affiliates make markets
in and trade various financial instruments or products for our accounts and for the account of our clients and otherwise provide investment
banking and other financial services with respect to these financial instruments and products. These financial instruments and products
may include securities, derivative instruments or assets that may relate to the Index or its components. In any such market making, trading
and hedging activity, investment banking and other financial services, we or our affiliates may take positions or take actions that are
inconsistent with, or adverse to, the investment objectives of the holders of the securities. We and our affiliates have no obligation
to take the needs of any buyer, seller or holder of the securities into account in conducting these activities. Such market making, trading
and hedging activity, investment banking and other financial services may negatively impact the value of the securities. Participating
dealers may also engage in such activities that may negatively impact the value of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition, the
role played by Barclays Capital Inc., as the agent for the securities, could present significant conflicts of interest with the role of
Barclays Bank PLC, as issuer of the securities. For example, Barclays Capital Inc. or its representatives may derive compensation or financial
benefit from the distribution of the securities and such compensation or financial benefit may serve as an incentive to sell the securities
instead of other investments. Furthermore, we and our affiliates establish the offering price of the securities for initial sale to the
public, and the offering price is not based upon any independent verification or valuation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">Furthermore, if any
dealer participating in the distribution of the securities or any of its affiliates conducts hedging activities for us in connection with
the securities, that participating dealer or its affiliates will expect to realize a projected profit from such hedging activities, and
this projected profit will be in addition to any selling concession and/or any fee that the participating dealer realizes for the sale
of the securities to you. This additional projected profit may create a further incentive for the participating dealer to sell the securities
to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">In addition to the
activities described above, Barclays Bank PLC will also act as the calculation agent for the securities. As calculation agent, we will
determine any levels of the Index and make any other determinations necessary to calculate any payments on the securities. In making these
determinations, we may be required to make discretionary judgments, including those described in the accompanying product supplement and
under &ldquo;&mdash;Risks Relating to the Index&rdquo; above. In making these discretionary judgments, our economic interests are potentially
adverse to your interests as an investor in the securities, and any of these determinations may adversely affect any payments on the securities.
Absent manifest error, all determinations of the calculation agent will be final and binding, without any liability on the part of the
calculation agent. You will not be entitled to any compensation from Barclays Bank PLC for any loss suffered as a result of any determinations
made by the calculation agent with respect to the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Risks Relating to the Estimated
Value of the Securities and the Secondary Market</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Securities Will Not Be Listed On Any Securities
Exchange And We Do Not Expect A Trading Market For The Securities To Develop</B> &mdash; The securities will not be listed on any securities
exchange. Barclays Capital Inc. and other affiliates of Barclays Bank PLC intend to make a secondary market for the securities but are
not required to do so, and may discontinue any such secondary market making at any time, without notice. Even if there is a secondary
market, it may not provide enough liquidity to </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">allow you to trade
or sell the securities easily. Because other dealers are not likely to make a secondary market for the securities, the price at which
you may be able to trade your securities is likely to depend on the price, if any, at which Barclays Capital Inc. and other affiliates
of Barclays Bank PLC are willing to buy the securities. The securities are not designed to be short-term trading instruments. Accordingly,
you should be willing and able to hold your securities to maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Value Of The Securities Prior To Maturity
Will Be Affected By Numerous Factors, Some Of Which Are Related In Complex Ways</B> &mdash; Structured notes, including the securities,
can be thought of as securities that combine a debt instrument with one or more options or other derivative instruments. As a result,
the factors that influence the values of debt instruments and options or other derivative instruments will also influence the terms and
features of the securities at issuance and their value in the secondary market. Accordingly, in addition to the level of the Index on
any day, the value of the securities will be affected by a number of economic and market factors that may either offset or magnify each
other, including:</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the expected volatility of the Index;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the time to maturity of the securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the market prices of, and dividend rates on,
the securities composing the Index;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">interest and yield rates in the market generally;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">supply and demand for the securities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">a variety of economic, financial, political,
regulatory and judicial events; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our creditworthiness, including actual or anticipated
downgrades in our credit ratings.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of Your Securities Is
Lower Than The Original Offering Price Of Your Securities</B> &mdash; The estimated value of your securities on the pricing date is lower
than the original offering price of your securities. The difference between the original offering price of your securities and the estimated
value of the securities is a result of certain factors, such as any sales commissions, selling concessions, discounts, commissions or
fees to be allowed or paid to Barclays Capital Inc., another affiliate of ours, WFS or its affiliates or other non-affiliated intermediaries,
the estimated profit that we or any of our affiliates expect to earn in connection with structuring the securities, the estimated cost
that we may incur in hedging our obligations under the securities, and estimated development and other costs that we may incur in connection
with the securities.&#9;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of Your Securities Might
Be Lower If Such Estimated Value Were Based On The Levels At Which Our Debt Securities Trade In The Secondary Market</B> &mdash; The estimated
value of your securities on the pricing date is based on a number of variables, including our internal funding rates. Our internal funding
rates may vary from the levels at which our benchmark debt securities trade in the secondary market. As a result of this difference, the
estimated value referenced above might be lower if such estimated value were based on the levels at which our benchmark debt securities
trade in the secondary market.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of The Securities Is Based
On Our Internal Pricing Models, Which May Prove To Be Inaccurate And May Be Different From The Pricing Models Of Other Financial Institutions</B>
&mdash; The estimated value of your securities on the pricing date is based on our internal pricing models, which take into account a
number of variables and are based on a number of subjective assumptions, which may or may not materialize. These variables and assumptions
are not evaluated or verified on an independent basis. Further, our pricing models may be different from other financial institutions&rsquo;
pricing models and the methodologies used by us to estimate the value of the securities may not be consistent with those of other financial
institutions that may be purchasers or sellers of securities in the secondary market. As a result, the secondary market price of your
securities may be materially different from the estimated value of the securities determined by reference to our internal pricing models.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Estimated Value Of Your Securities Is
Not A Prediction Of The Prices At Which You May Sell Your Securities In The Secondary Market, If Any, And Such Secondary Market Prices,
If Any, Will Likely Be Lower Than The Original Offering Price Of Your Securities And May Be Lower Than The Estimated Value Of Your Securities</B>
&mdash; The estimated value of the securities will not be a prediction of the prices at which Barclays Capital Inc., other affiliates
of ours or third parties may be willing to purchase the securities from you in secondary market transactions (if they are willing to purchase,
which they are not obligated to do). The price at which you may be able to sell your securities in the secondary market at any time will
be influenced by many factors that cannot be predicted, such as market conditions, and any bid and ask spread for similar sized trades,
and may be substantially less than our estimated value of the securities. Further, as secondary market prices of your securities take
into account the levels at which our debt securities trade in the secondary market, and do not take into account our various costs related
to the securities such as fees, commissions, discounts, and the costs of hedging our obligations under the securities, secondary market
prices of your securities will likely be lower than the original offering price of your securities. As a result, the price at which Barclays
Capital Inc., other affiliates of ours or third parties may be willing to purchase the securities from you in secondary market transactions,
if any, will likely be lower than the price you paid for your securities, and any sale prior to the stated maturity date could result
in a substantial loss to you.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>The Temporary Price At Which We May Initially
Buy The Securities In The Secondary Market And The Value We May Initially Use For Customer Account Statements, If We Provide Any Customer
Account Statements At All, May Not Be Indicative Of Future Prices Of Your Securities</B> &mdash; Assuming that all relevant factors remain
constant after the pricing date, the price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market
(if Barclays Capital Inc. makes a market in the securities, which it is not obligated to do) and the value that we may initially use for
customer account statements, if we provide any customer account statements at all, may exceed our estimated value of the securities on
the pricing date, as well as the secondary market value of the securities, for a temporary period after the initial issue date of the
securities. The price at which Barclays Capital Inc. may initially buy or sell the securities in the secondary market and the value that
we may initially use for customer account statements may not be indicative of future prices of your securities.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #5E8AB4"><FONT STYLE="font-size: 12pt">Hypothetical
Examples and Returns</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The payout profile, return table and examples
below illustrate the maturity payment amount for a $1,000 principal amount security on a hypothetical offering of securities under various
scenarios, with the assumptions set forth in the table below. Terms used for purposes of these hypothetical examples do not represent
the actual starting level, threshold level or ending level applicable to the securities. The actual maturity payment amount and resulting
pre-tax total rate of return will depend on the actual terms of the securities. You should not take these examples as an indication or
assurance of the expected performance of the securities. These examples are for purposes of illustration only. The values used in the
examples may have been rounded for ease of analysis. The examples below do not take into account any tax consequences from investing in
the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 95%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 36%; border: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Upside Participation Rate: </B></FONT></TD>
    <TD STYLE="width: 64%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">100%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Maximum Upside Return: </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">18.50% of the principal amount or $185.00 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hypothetical Starting Level: </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">100.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hypothetical Threshold Level: </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">85.00 (85% of the hypothetical starting level)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Buffer Amount: </B></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">15%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The hypothetical starting level of 100.00 has
been chosen for illustrative purposes only and does not represent the actual starting level. The actual starting level and threshold level
are set forth under &ldquo;Terms of the Securities&rdquo; above and the actual ending level will be the closing level of the Index on
the calculation day. For historical closing levels of the Index, see the historical information set forth under the section titled &ldquo;The
S&amp;P 500<SUP>&reg;</SUP> Index&rdquo; below. We cannot predict the closing level of the Index on any day during the term of the securities,
including on the calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Payout Profile</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><IMG SRC="image_003.jpg" ALT="" STYLE="height: 350px; width: 552px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Returns</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 23%; border: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical<BR>
ending level</B></FONT></TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical<BR>
index return</B></FONT></TD>
    <TD STYLE="width: 19%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Absolute value return</B></FONT></TD>
    <TD STYLE="width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical maturity payment amount per security</B></FONT></TD>
    <TD STYLE="width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Hypothetical pre-tax total rate of return</B></FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">175.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,185.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.50%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">150.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,185.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.50%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">140.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,185.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.50%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">130.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,185.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.50%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">120.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,185.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.50%</FONT></TD></TR>
  <TR STYLE="background-color: #CCCCCC">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">118.50</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.50%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,185.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.50%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">110.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,100.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">105.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,050.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">102.50</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,025.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50%</FONT></TD></TR>
  <TR STYLE="background-color: #CCCCCC">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">100.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">97.50</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-2.50%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,025.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">95.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-5.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,050.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">90.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-10.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,100.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.00%</FONT></TD></TR>
  <TR STYLE="background-color: #CCCCCC">
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">85.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-15.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.00%</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$1,150.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">84.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-16.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$990.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-25.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$900.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-10.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-50.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$650.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-35.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-75.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$400.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-60.00%</FONT></TD></TR>
  <TR>
    <TD STYLE="white-space: nowrap; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-100.00%</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$150.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-85.00%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>Hypothetical Examples</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 1. Maturity payment amount is greater
than the principal amount and reflects a return that is less than the maximum upside return:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">Hypothetical starting level: 100.00<BR>
Hypothetical ending level: 110.00<BR>
Hypothetical threshold level: 85.00<BR>
Hypothetical index return: 10.00%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending level is greater
than the hypothetical starting level, the maturity payment amount per security would be equal to the principal amount of $1,000 <I>plus</I>
a positive return equal to the <I>lesser</I> of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(i) $1,000 &times; index return &times; upside
participation rate</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,000 &times; 10.00% &times; 100%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $100.00; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(ii) the maximum upside return of $185.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$1,100.00 per security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 2. Maturity payment amount is greater
than the principal amount and reflects a return equal to the maximum upside return:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">Hypothetical starting level: 100.00<BR>
Hypothetical ending level: 140.00<BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">Hypothetical threshold level: 85.00<BR>
Hypothetical index return: 40.00%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending level is greater
than the hypothetical starting level, the maturity payment amount per security would be equal to the principal amount of $1,000 <I>plus</I>
a positive return equal to the <I>lesser</I> of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(i) $1,000 &times; index return &times; upside
participation rate</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,000 &times; 40.00% &times; 100%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $400.00; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(ii) the maximum upside return of $185.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$1,185.00 per security, which is the maximum maturity payment amount if the Index appreciates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 3. Maturity payment amount is greater
than the principal amount and reflects the absolute value return:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">Hypothetical starting level: 100.00<BR>
Hypothetical ending level: 90.00<BR>
Hypothetical threshold level: 85.00<BR>
Hypothetical index return: -10.00%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending level is less
than the hypothetical starting level, but not by more than 15%, the maturity payment amount per security would be equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + ($1,000 &times; absolute value return)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Because the index return is -10.00%, the absolute value return is +10.00%
and the maturity payment amount is calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,000 + ($1,000 &times; 10.00%)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,100.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$1,100.00 per security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 4. Maturity payment amount is less
than the principal amount:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">Hypothetical starting level: 100.00<BR>
Hypothetical ending level: 50.00<BR>
Hypothetical threshold level: 85.00<BR>
Hypothetical index return: -50.00%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because the hypothetical ending level is less
than the hypothetical starting level by more than 15%, you would lose a portion of the principal amount of your securities and receive
the maturity payment amount equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,000 + [$1,000 &times; (index return + buffer
amount)]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $1,000 + [$1,000 &times; (-50.00% + 15%)]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">= $650.00</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you would receive
$650.00 per security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #5E8AB4"><FONT STYLE="font-size: 12pt">The
S&amp;P 500<SUP>&reg;</SUP> Index</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Index consists of stocks of 500 companies
selected to provide a performance benchmark for the U.S. equity markets. For more information about the Index, see &ldquo;Indices&mdash;The
S&amp;P U.S. Indices&rdquo; in the accompanying underlying supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Historical Information</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We obtained the closing levels displayed in the
graph below from Bloomberg Professional<SUP>&reg;</SUP> service without independent verification. The historical performance of the Index
should not be taken as an indication of the future performance of the Index. Future performance of the Index may differ significantly
from historical performance, and no assurance can be given as to the closing levels of the Index during the term of the securities, including
on the calculation day. We cannot give you assurance that the performance of the Index will not result in a loss on your initial investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following graph sets forth daily closing levels
of the Index for the period from January 1, 2020 to October 31, 2025. The closing level on October 31, 2025 was 6,840.20.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 9pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><IMG SRC="image_004.jpg" ALT="" STYLE="height: 322px; width: 614px"></B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">* The dotted line indicates the threshold level of 85% of the starting level.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">PAST PERFORMANCE IS NOT
INDICATIVE OF FUTURE RESULTS.<BR STYLE="clear: both">
</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #5E8AB4"><FONT STYLE="font-size: 12pt">Tax
Considerations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should review carefully the sections in the
accompanying prospectus supplement entitled &ldquo;Material U.S. Federal Income Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes
Treated as Prepaid Forward Contracts&rdquo; and, if you are a non-U.S. holder, &ldquo;&mdash;Tax Consequences to Non-U.S. Holders.&rdquo;
The following discussion, when read in combination with those sections, constitutes the full opinion of our special tax counsel, Davis
Polk &amp; Wardwell LLP, regarding the material U.S. federal income tax consequences of owning and disposing of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on current market conditions, in the opinion
of our special tax counsel, it is reasonable to treat the securities for U.S. federal income tax purposes as prepaid forward contracts
with respect to the Index. Assuming this treatment is respected, if you are a U.S. holder, upon a sale or exchange of the securities (including
redemption at maturity), you should recognize capital gain or loss equal to the difference between the amount realized on the sale or
exchange and your tax basis in the securities, which should equal the amount you paid to acquire the securities. This gain or loss on
your securities should be treated as long-term capital gain or loss if you hold your securities for more than a year, whether or not you
are an initial purchaser of the securities at the original issue price. The deductibility of capital losses is subject to limitations.
However, the IRS or a court may not respect this treatment, in which case the timing and character of any income or loss on the securities
could be materially and adversely affected. In addition, in 2007 the U.S. Treasury Department and the IRS released a notice requesting
comments on the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo; and similar instruments. The notice focuses
in particular on whether to require investors in these instruments to accrue income over the term of their investment. It also asks for
comments on a number of related topics, including the character of income or loss with respect to these instruments; the relevance of
factors such as the nature of the underlying property to which the instruments are linked; the degree, if any, to which income (including
any mandated accruals) realized by non-U.S. investors should be subject to withholding tax; and whether these instruments are or should
be subject to the &ldquo;constructive ownership&rdquo; regime, which very generally can operate to recharacterize certain long-term capital
gain as ordinary income and impose a notional interest charge. While the notice requests comments on appropriate transition rules and
effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely
affect the tax consequences of an investment in the securities, possibly with retroactive effect. You should consult your tax advisor
regarding the U.S. federal income tax consequences of an investment in the securities, including possible alternative treatments and the
issues presented by this notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Treasury regulations under Section 871(m) generally
impose a withholding tax on certain &ldquo;dividend equivalents&rdquo; under certain &ldquo;equity linked instruments.&rdquo; A recent
IRS notice excludes from the scope of Section 871(m) instruments issued prior to January 1, 2027 that do not have a &ldquo;delta of one&rdquo;
with respect to underlying securities that could pay U.S.-source dividends for U.S. federal income tax purposes (each an &ldquo;Underlying
Security&rdquo;). Based on our representation that the securities do not have a &ldquo;delta of one&rdquo; within the meaning of the regulations,
our special tax counsel believes that these regulations should not apply to the securities with regard to non-U.S. holders, and we have
determined to treat the securities as not being subject to Section 871(m). Our determination is not binding on the IRS, and the IRS may
disagree with this determination. Section 871(m) is complex and its application may depend on your particular circumstances, including
whether you enter into other transactions with respect to an Underlying Security. You should consult your tax advisor regarding the potential
application of Section 871(m) to the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Non-U.S. holders should also discuss with their
tax advisors the estate tax consequences of investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="color: #BB0826; font: bold 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Market Linked Securities&mdash;Upside Participation to a Cap with Contingent Absolute Return and Fixed Percentage Buffered Downside</P><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the S&amp;P 500<SUP>&reg;</SUP> Index due May 4, 2028</B></P><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt; padding: 4pt; color: white; text-align: center; background-color: #5E8AB4"><FONT STYLE="font-size: 12pt">Validity
of the Securities</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of Davis Polk &amp; Wardwell LLP,
as special United States products counsel to Barclays Bank PLC, when the securities offered by this pricing supplement have been issued
by Barclays Bank PLC pursuant to the indenture, the trustee has made, in accordance with instructions from Barclays Bank PLC, appropriate
entries or notations in its records relating to the master global note that represents such securities (the &ldquo;master note&rdquo;),
and such securities have been delivered against payment as contemplated herein, such securities will be valid and binding obligations
of Barclays Bank PLC, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting
creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general applicability (including, without limitation,
concepts of good faith, fair dealing and the lack of bad faith) and possible judicial or regulatory actions or application giving effect
to governmental actions or foreign laws affecting creditors&rsquo; rights, <I>provided </I>that such counsel expresses no opinion as to
(i) the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed above
or (ii) the validity, legally binding effect or enforceability of any provision that permits holders to collect any portion of the stated
principal amount upon acceleration of the securities to the extent determined to constitute unearned interest. This opinion is given as
of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by English law,
Davis Polk &amp; Wardwell LLP has relied, with Barclays Bank PLC&rsquo;s permission, on the opinion of Davis Polk &amp; Wardwell London
LLP, dated as of May 15, 2025, filed as an exhibit to the Registration Statement on Form F-3ASR by Barclays Bank PLC on May 15, 2025,
and this opinion is subject to the same assumptions, qualifications and limitations as set forth in such opinion of Davis Polk &amp; Wardwell
London LLP. In addition, this opinion is subject to customary assumptions about the trustee&rsquo;s authorization, execution and delivery
of the indenture and its authentication of the master note and the validity, binding nature and enforceability of the indenture with respect
to the trustee, all as stated in the opinion of Davis Polk &amp; Wardwell LLP, dated May 15, 2025, which has been filed as an exhibit
to the Registration Statement referred to above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</P><P STYLE="font-size: 10pt; margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp236849_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.2b -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: 4c50ac9aec6e5e24c3293f98d0e477d1 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0000312070</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="fee_004">333-287303</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" xs:nil="true" id="fee_005"></ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="c_report" id="fee_007">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000312070</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-04</xbrli:startDate>
          <xbrli:endDate>2025-11-04</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000312070</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-04</xbrli:startDate>
          <xbrli:endDate>2025-11-04</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_008">F-3</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_009">BARCLAYS BANK PLC</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_010">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="fee_011">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="fee_012">Global Medium-Term Notes, Series A</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_013">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_014">2,039</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_015">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_016">2,039,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="fee_017">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-223">281.59</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-224">2,039,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-225">281.59</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-226">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-227">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-228">281.59</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-229">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), was originally deferred in accordance with Rule 456(b) under the Securities Act.</ix:nonNumeric></td></tr>
  </table>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-230">2,039,000</ix:nonFraction>.
<ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-231">The prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1"  J +,# 2(  A$! Q$!_\0
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MO;H[H[-!#"#Z^OY5:\5Z%<RW*:EI^XS1@!E7[W'1A_A5CP,!_8.1U\ULT?\
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CD([LH-6**+@XI[HCCACB4+&H51T"C J2BB@:5@HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &L KT# 2(  A$! Q$!_\0
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M  L+7?\ H7-._P#!L_\ \CT<DNP<\>YZ+17G7_"PM=_Z%S3O_!L__P CT?\
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M<W6J'O\ VK??^E,M:4U=F=5VB3T445T'*%%%22030A#+$Z!UW(64C</4>HH
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MN#DA<G.*BTC4;M_#&M7%UK";?[+$DFS4Y998+D!LEB57R&)*CR@>"IP.M/E
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M'!ST8CH!C#:]CN="OE&J7$]N^AR2:HTM[)F"\&W:IRW[IB3(#&-HXQC'%+E
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MQJ64:6WB9XU@B*^6^U5=F49C)R#D$Y]_7UJ5([>ZTF!9+9<BTN)48,WR$.Q
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MACG.T@*<-G&0,T68&[167>ZR;/3K:[73;^X,X!\B*-0\8VEB7WLJI@#')ZX
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M3E_)'V98SAFE'F94#OC)!X."0#S\WD=/+YB_;?%?_0-MO^^A_P#%T?;?%?\
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ME4,V0CEMB/L/4EN3TXQ6G>>#);JYNIEO+&(O;R6\$BV!$JHZ[0DCB0>8JKG
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M-;YX)I0UBS8EC$8RO[T84^6/E.2,]:ELO"LMI/;?Z=$]M8R2SV,1MB&CDD#
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M;Q5_V$H__2.VK.K\(T:->=O<Q6G@B\U&XO&L[PZU(TLHN#"2PNBFUB"-P$0
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M&Y:V%O$/,=)T#.D>W!# %DP#R"G/'!8#KXM*TZ"YN+F&PM8Y[D8GE2%0TO\
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MJ[A1116ID%%%% !1110 4444 %%%% !1110 4444 %=5\-/^/;Q#_P!A4?\
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MJK'$,.I )'R<!AN!_'&#S5V75M?M=26RLYKNXAL(+65Y)/LJ)*DC'>TI;:0
MH(7RP.5YS2LQG2W?A>Q?PG?:%8V]O9QW5N\9,$(1=[+C>0._ _*J>LPZS?:!
M#</<6^FO",WL%U&DT+!64E]P92% 4L,D94G*@]'^(;J_L-6M'CU"XBM+R&6U
M2*-(R%NB-T399"><,.3C(7CDYS+76=2B\8V5A_:5W>VKW3V4SR001Q;TMBYQ
MCYR^Y<D\)AL <4*X%RP\.R+_ &%<:1K%HVG:?;F.'_1O-,JN &8.L@7L,87
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MV0,V[ALD#G/?UI4\/Z+%]E\O2+!/LA)MMML@\DDY.SCY>>>.];'_  @G@_\
MZ%30_P#P70__ !-'_"">#_\ H5-#_P#!=#_\31[)]PN5GCCDV[T5MK!EW#.#
MZCWK/N/#VB7=R]S<Z/I\T\C!GEDMD9F(& 22,D@<5L_\()X/_P"A4T/_ ,%T
M/_Q-'_"">#_^A4T/_P %T/\ \32]EYA<PF\+^'WBBB;0M,,<081H;2,A W4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %8MQ_R-UG_P!>S_SK:KEKS6;2/Q-%
M,Q<+;J\+_+SNR!P/3FJBB9.QU-%%%24%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0:*\^_L"W_Z"&N?^#N\_^.T?V!;_ /00US_P=WG_ ,=HYT%CT&BO/O[ M_\
MH(:Y_P"#N\_^.T?V!;_]!#7/_!W>?_':.=!8]!HKS[^P+?\ Z"&N?^#N\_\
MCM']@6__ $$-<_\ !W>?_':.=!8]!HKS[^P+?_H(:Y_X.[S_ ..T?V!;_P#0
M0US_ ,'=Y_\ ':.=!8]!HKS[^P+?_H(:Y_X.[S_X[1_8%O\ ]!#7/_!W>?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%%% "$!E*L 01@@]Z9!!#;01P6\210QJ%2.-0JJ!T  X J2B@ HHHH ****
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M)L3R*I*XVL%#8#C:N' ##'!J>'2+"#39=/%N'MI0PE69C(9=W7>S$EB?4DT
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M_>9%W;48\Y90"<GGFC09SF@1:E:> 9=3LET^76+B,W)D^R$>>1DXDP^78_,
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M444 %%%% !1110 4444 %%%% !7GV@?\>E]_V%=0_P#2N:O0:\^T#_CTOO\
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MT!)1?-8)GU* [6(QD$@X/(Q5FBX!1112 **** "BBB@ HHHH **** "BBB@
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61110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %> B@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !14<\\5M \TTBQQ(,LS'
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M.>.:CU+P7.VF7D%O>O<(Q,T-JZJ@\[RA$I+_ -T8W8]?RH V$\6Z27*R3LB
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M4 6KWQ9I=C<-;R-.\RG;Y<4#.?\ 5^9V']WG_P"O5G2=>L=;\W[&TI\M4?\
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M\M;M\T+?]\G;]4-=;0 4444 %%%5+S4$M$^6*6XEW!1%"-S9/3/8#W- %LD
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MLK6%D7=;-->H-XP?F8#)49!_ &NL@9GMXW?;O9 6V=,X[9[4 2444A(4$D@
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MP9XKN[?SKM$V[AD(I[E5SQ5Z@"M96,-C$4B+L68L[R.69CZDFK-%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>IK/62^U*..2+S+"(2'<)4!D=1C&!_#GGKS4UOIR(T4UTWVJ[C! G=0",G/
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6+JG_1/O$_\ WY3_ .*H [ZBN!_X6+JG_1/O$_\ WY3_ .*ILOQ*U&&)Y9?
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MX6+JG_1/O$__ 'Y3_P"*JK<_%B>SN[2UN? _B.*>[8I;QM$@,I R0/FYP.:
M/2**X'_A8NJ?]$^\3_\ ?E/_ (JC_A8NJ?\ 1/O$_P#WY3_XJ@#OJ*X'_A8N
MJ?\ 1/O$_P#WY3_XJC_A8NJ?]$^\3_\ ?E/_ (J@#OJ*X'_A8NJ?]$^\3_\
M?E/_ (JJL?Q7GFU*?3H_ _B-KR!%DEA$2;D5NA(W=#B@#TBBN!_X6+JG_1/O
M$_\ WY3_ .*H_P"%BZI_T3[Q/_WY3_XJ@#OJ*X'_ (6+JG_1/O$__?E/_BJ/
M^%BZI_T3[Q/_ -^4_P#BJ .^HK@?^%BZI_T3[Q/_ -^4_P#BJJV'Q7GU2!Y[
M'P/XCN(DD:)GCB0@.IPP^]U!H ](HK@?^%BZI_T3[Q/_ -^4_P#BJ/\ A8NJ
M?]$^\3_]^4_^*H [ZBN!_P"%BZI_T3[Q/_WY3_XJC_A8NJ?]$^\3_P#?E/\
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M#9MO$FAV-M!:0QO:HCF'[.+<I]GP5'S*/NK\Z<]/F%;EM=17:.\62BNR;B,
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MQXA5"A=5!' .Q2P'H*P+7P[J^GZ@^J6EE#AO.C2Q>YR8PZQ_,9"#N):/)'.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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*1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %" F8# 2(  A$! Q$!_\0
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M =+_ / ./_"M>B@#(_X17P[_ - '2_\ P#C_ ,*/^$5\._\ 0!TO_P  X_\
M"M>B@#(_X17P[_T =+_\ X_\*/\ A%?#O_0!TO\ \ X_\*UZ* ,C_A%?#O\
MT =+_P# ./\ PH_X17P[_P! '2__  #C_P *UZ* ,C_A%?#O_0!TO_P#C_PH
M_P"$5\._] '2_P#P#C_PK7HH R/^$5\._P#0!TO_ , X_P#"C_A%?#O_ $ =
M+_\  ./_  K7HH R/^$5\._] '2__ ./_"C_ (17P[_T =+_ / ./_"M>B@#
M(_X17P[_ - '2_\ P#C_ ,*/^$5\._\ 0!TO_P  X_\ "M>B@#(_X17P[_T
M=+_\ X_\*/\ A%?#O_0!TO\ \ X_\*UZ* ,C_A%?#O\ T =+_P# ./\ PH_X
M17P[_P! '2__  #C_P *UZ* ,C_A%?#O_0!TO_P#C_PH_P"$5\._] '2_P#P
M#C_PK7HH R/^$5\._P#0!TO_ , X_P#"C_A%?#O_ $ =+_\  ./_  K7HH R
M/^$5\._] '2__ ./_"C_ (17P[_T =+_ / ./_"M>B@#(_X17P[_ - '2_\
MP#C_ ,*/^$5\._\ 0!TO_P  X_\ "M>B@#(_X17P[_T =+_\ X_\*/\ A%?#
MO_0!TO\ \ X_\*UZ* ,C_A%?#O\ T =+_P# ./\ PH_X17P[_P! '2__  #C
M_P *UZ* ,C_A%?#O_0!TO_P#C_PH_P"$5\._] '2_P#P#C_PK7HH R/^$5\.
M_P#0!TO_ , X_P#"C_A%?#O_ $ =+_\  ./_  K69E099@H]2<4M &1_PBOA
MW_H Z7_X!Q_X4?\ "*^'?^@#I?\ X!Q_X5KT4 9'_"*^'?\ H Z7_P" <?\
MA1_PBOAW_H Z7_X!Q_X5KT4 9'_"*^'?^@#I?_@''_A1_P (KX=_Z .E_P#@
M''_A6O10!D?\(KX=_P"@#I?_ (!Q_P"%'_"*^'?^@#I?_@''_A6O10!D?\(K
MX=_Z .E_^ <?^%'_  BOAW_H Z7_ . <?^%:]% &1_PBOAW_ * .E_\ @''_
M (4?\(KX=_Z .E_^ <?^%:]% &1_PBOAW_H Z7_X!Q_X4?\ "*^'?^@#I?\
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MSK%\L]C<ONM4!4E<':-V ,':JGCCDYR>:ZRBB@ HHHH **** "BBB@ HHHH
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MXX^G'2M***.&)(HD5(T4*J*,!0.@ IU% '/Z?_R/6N_]>=G_ #FKH*Y_3_\
MD>M=_P"O.S_G-704 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'<-HP[#CK_"@ _"L:Z\#-?0M8SWRC3XY)YK95B_>))+DY)S@A2S8X&<C/3D
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%07=Q]EMS($,C9"JBG!8DX %"5PV)ZI7.JVENAQ/')+
MCY(T8$L>PX]ZSYXM8OOWX#V9R(EA$@)"-C<Y(XW#MZ8/K6E;:99V9)@MT4E@
MQ..<A=N?KCO6G+%;D7;V,^[TJ\N(5D:X62[65'0XPD/S#<5'?CIG^M%E;1VG
MB1X(A\J6$?U)\Q\D^Y/-;=9*?\C;/_UXQ_\ HQZES;5AJ*3N:U%%%24%%%%
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MI1 (O%YP?NMW&?3T% &G169_PD.E8S]L7'7[K>F[T].:#X@TI<YO%XSGY6[
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M4 %%%% !1110 4444 %%%% !1110 4444 %9*?\ (VS_ /7C'_Z,>M:LE/\
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M@,YZ7![@#^E &G16:='!S_Q,-0&<]+@\9Q_A_.@Z."2?[0U#G/\ R\'US_\
M6^E &E16;_8XSG^T-0_\"#ZY_P#K?2J=S#:6+A)=4U$R *1&LQ9FY/8#GO\
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M *WTI.392BD:1 (P1D&JT-A:P7,MS% BS2XWL.^!@?3CTJM_8XSG^T-0_P#
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MB/7'^E#GGC^'TR:TJ* ,W[7JN?\ D%Q8_P"OH>N/[OIS^E N]5R,Z5$.F?\
M2AZ\_P /IS6E10!FB[U8XSI40SC/^E#CKG^'MQ^= N]6.,Z5$.F?]+'''/\
M#ZX%:5% &9]KU;'_ ""HL_\ 7V/3/]WUX_6E-WJV#C2HCUQ_I8]./X?7BM*B
M@#--WJPSC2HCC./]+'/3'\/?G\J#=ZJ,XTJ(]<?Z4.>>/X?3)K2HH S?M>JY
M_P"07%C_ *^AZX_N^G/Z4"[U7(SI40Z9_P!*'K_N^G-:5% &:+O5CC.E1#.,
M_P"E#CKG^'Z?G0+O5CC.E1#IG_2QQP<_P^N!^-:5% &9]KU;'_(*BS_U]CTS
M_=]>/UJK8R7,OBJY-S;K PLHPH63?D;VYZ#'.1^%;M9*?\C;/_UXQ_\ HQZ
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MI69SC&)UYST[^Q_*@:SI9'&I6?/_ $W7TSZ^G-067:*H_P!LZ7C/]I6?_?\
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M(/\ T6M:] !2,"4(#%21P1VI:* .>TOP_>Z)8RPVFI>?)(X<R3PJ&9BP+.[
M99B,C\NF*BF\%65R98I[FX>R+3/%;< 1/+G<P.,GDL1GID^U=-10!S?_  B9
M^T?;_P"U+C^UO,W?;/+3.-FS;LQMQCGZ\UM:;I\&E:;;V%L&\F! B[CDG'<G
MU-6J* .;T^"'_A.=<'DQX^QV?\(]9JZ#[/#_ ,\8_P#OD5AZ?_R/6N_]>=G_
M #FKH* (_L\/_/&/_OD4?9X?^>,?_?(J2B@"/[/"/^6,?_?(H^SP_P#/&/\
M[Y%244 1_9X?^>,?_?(H^SP_\\8_^^14E% $?V>'_GC'_P!\BC[/#_SQC_[Y
M%244 1_9X?\ GC'_ -\BC[/#_P \8_\ OD5)10!']GA_YXQ_]\BC[/#_ ,\8
M_P#OD5)10!']GA_YXQ_]\BC[/#_SQC_[Y%244 1_9X?^>,?_ 'R*/L\/_/&/
M_OD5)10!']GA_P">,?\ WR*/L\/_ #QC_P"^14E% $?V>'_GC'_WR*/L\/\
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M_(H:)_UX0?\ HM:UZR/"O_(H:)_UX0?^BUK7H **** "BBB@ HHHH Y_3_\
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MR00WE\(9I(FVMMV.P4,.1DJ!D<T[PI=7%WH0:XE:9H[B>%)6.3(B2LJL3W.
M.>]:MU:6U];M;W<$<\+8)210P..1P:8[V>DZ>68PVMG;I[*B*/Y4 <G%JUY9
M^--6E;P]JL@EM+7:(O); #3#)_>=^WT-:O\ PDUU_P!"OKO_ 'Q#_P#':U-/
MO=/U2(WVGS07"M^[:6,@GY<_*>XQD\'IFKE '/\ _"377_0KZ[_WQ#_\=H_X
M2:Z_Z%?7?^^(?_CM=!10!S__  DUU_T*^N_]\0__ !VHI_%TMM&KS>&=<56=
M8P?+A^\S!5'^M[D@5TM9XU32;S4)-,%Y:S7D)#M;;U+J000=OJ#@^W% &?\
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M_0KZ[_WQ#_\ ':/^$FNO^A7UW_OB'_X[7044 <__ ,)-=?\ 0KZ[_P!\0_\
MQVHE\7R/<RVR^&=<,T2J[KY</ ;.#_K?]D_E6_=W=O8VLEU=S)#!$-SR2-A5
M'UJ*PN;'4(!J%A+#/', /.B(.X GC/L2>.W- &5_PDUU_P!"OKO_ 'Q#_P#'
M:/\ A)KK_H5]=_[XA_\ CM=!10!S_P#PDUU_T*^N_P#?$/\ \=H_X2:Z_P"A
M7UW_ +XA_P#CM=!10!S-SXODM(#-/X:UQ(P0"?+A/)( _P"6OJ14W_"377_0
MKZY_WQ#_ /':OMJ>DW>I/H[75M+>*N]K8L"V!@]/;@^W%:- '/\ _"377_0K
MZ[_WQ#_\=H_X2:Z_Z%?7?^^(?_CM=!10!S__  DUU_T*^N_]\0__ !VC_A)K
MK_H5]=_[XA_^.UT%5+_5+#2HDDU"\@M4=MBM-($!/H,T 8L'B^2Y5VA\,ZXP
M21HV/EP\,IP1_K?45+_PDUU_T*^N_P#?$/\ \=K=CBCB4B)%0,Q<[1C)/)/U
M-/H Y_\ X2:Z_P"A7UW_ +XA_P#CM'_"377_ $*^N_\ ?$/_ ,=KH** .?\
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MM:]G+;7L,>H6ZY$\8*R-&59DZCJ,XY)Y]:LT <__ ,)-=?\ 0KZ[_P!\0_\
MQVC_ (2:Z_Z%?7?^^(?_ ([7044 <_\ \)-=?]"OKO\ WQ#_ /':BN/%TMK$
M))O#.N*A94SY</5F"@?ZWU(%=+5-+RQOKJYL5>.>6V*&9-N0C'YER>F> <=1
MP?2@#+_X2:Z_Z%?7?^^(?_CM'_"377_0KZ[_ -\0_P#QVN@HH Y__A)KK_H5
M]=_[XA_^.TNE7%SJ&O7%Y+I=[8Q"U2(?:@@+,&8G&UF]16_10 4444 %%%%
M'G?QE_Y%"T_Z_P!/_1<E%'QE_P"10M/^O]/_ $7)10!UOA7_ )%#1/\ KP@_
M]%K6O61X5_Y%#1/^O"#_ -%K6O0 4444 %%%% !7#Z]<:MJ<YL)XTM-.N+_[
M%"WEGSE=5\V.<$G:R[T'RXZ=^HK1\2>(WM&MK73[NVB,MQY%Q?.!-'9M@E1(
MH8$%CA03@<\]JKP^'I_$=I-_PD;WD<ZWBN8(I=L0"*5Q&1R8W#').&.2#C%
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MI/>_:[9&_P!$DDR95CQ]UV_B(Z!NI&,\\G(L?#%OJL6EZEK!OY[N 22-#=L
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M/B,W)=KQ9O(23;$H08 C9>6C8$G)Y;)SCI771QI#$D42*D: *JJ,!0.@ [4
M.HHHH *R]:N=2A6T@TR%#-<S>6T\J%T@7:S%F ()^[@<CDBKEW>V]DBF::)'
MD.R)'D5#(_95R1DFN+TO5=>U][1YI3%9RW/^DQ6:;)[&1,GR)MQ/RG RPP?^
M L#0!3DT^/7= MIK:Q)UF:6XN"MMJ!A\F8DQM..=Q3<HP.>O0UZ%:1S16<$=
MQ+YLZ1JLDF,;V Y./<UG:)X;T_0/M#6BNTMQ(SO+*VYL%BP0'LHR< ?SK7H
M***AGN[>U,0N)XXC-((H][ ;W/11ZDX/% $K$A20,D#IZUY[++<7UXS^)UAB
M2;2)Y41?W#6JNR(\3%B02<KAN,$'UJWK^LSIJEC?:/<+F>,Q6TC3!K2]?)S
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MO&%C%>:-YAL[R>ZA<-;26*J9H7Z;EW$ CL0>""0013/#'AB+2K:UNKB-EO1
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MJ\1?]!_5/_ R3_&BB@ _X2KQ%_T']4_\#)/\:/\ A*O$7_0?U3_P,D_QHHH
M/^$J\1?]!_5/_ R3_&C_ (2KQ%_T']4_\#)/\:** #_A*O$7_0?U3_P,D_QH
M_P"$J\1?]!_5/_ R3_&BB@ _X2KQ%_T']4_\#)/\:/\ A*O$7_0?U3_P,D_Q
MHHH /^$J\1?]!_5/_ R3_&C_ (2KQ%_T']4_\#)/\:** #_A*O$7_0?U3_P,
MD_QH_P"$J\1?]!_5/_ R3_&BB@ _X2KQ%_T']4_\#)/\:/\ A*O$7_0?U3_P
M,D_QHHH /^$J\1?]!_5/_ R3_&C_ (2KQ%_T']4_\#)/\:** #_A*O$7_0?U
M3_P,D_QH_P"$J\1?]!_5/_ R3_&BB@ _X2KQ%_T']4_\#)/\:/\ A*O$7_0?
MU3_P,D_QHHH /^$J\1?]!_5/_ R3_&C_ (2KQ%_T']4_\#)/\:** #_A*O$7
M_0?U3_P,D_QH_P"$J\1?]!_5/_ R3_&BB@ _X2KQ%_T']4_\#)/\:/\ A*O$
M7_0?U3_P,D_QHHH /^$J\1?]!_5/_ R3_&C_ (2KQ%_T']4_\#)/\:** #_A
M*O$7_0?U3_P,D_QH_P"$J\1?]!_5/_ R3_&BB@ _X2KQ%_T']4_\#)/\:/\
MA*O$7_0?U3_P,D_QHHH /^$J\1?]!_5/_ R3_&C_ (2KQ%_T']4_\#)/\:**
M #_A*O$7_0?U3_P,D_QH_P"$J\1?]!_5/_ R3_&BB@ _X2KQ%_T']4_\#)/\
M:/\ A*O$7_0?U3_P,D_QHHH R?$.OZS>Z?''=:M?SQB4,%EN78 X/."?<T44
$4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Nov. 04, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000312070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">BARCLAYS BANK PLC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-287303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings - Offering: 1<br></strong></div></th>
<th class="th">
<div>Nov. 04, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Global Medium-Term Notes, Series A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">2,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 2,039,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 281.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), was originally deferred in accordance with Rule 456(b) under the Securities Act.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Nov. 04, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 2,039,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">281.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">281.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 2,039,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp236849_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp236849_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp236849_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp236849_exfilingfees.htm">dp236849_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp236849_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp236849_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/ffd/2025": 6,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 24,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236849_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236849_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236849_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236849_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236849_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236849_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0000950103-25-014236-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-014236-xbrl.zip
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M     &1P,C,V.#0Y7V5X9FEL:6YG9F5E<RYH=&U02P4&      $  0!'
&Z0H

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>dp236849_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000312070</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000312070</identifier>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0000312070</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="fee_004">333-287303</ffd:RegnFileNb>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_005" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_006">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="c_report" id="fee_007">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_008">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_009">BARCLAYS BANK PLC</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_010">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="fee_011">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="fee_012">Global Medium-Term Notes, Series A</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="fee_013">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="fee_014"
      unitRef="shares">2039</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_015"
      unitRef="USD">1000</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_016"
      unitRef="USD">2039000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="fee_017"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-223"
      unitRef="USD">281.59</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-224"
      unitRef="USD">2039000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-225"
      unitRef="USD">281.59</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-226"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-227"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-228"
      unitRef="USD">281.59</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-229">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), was originally deferred in accordance with Rule 456(b) under the Securities Act.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-230"
      unitRef="USD">2039000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-231">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
